companydata.dkIMMUNITRACK ApS: Financial statements 2017
CVR: 32347908
IMMUNITRACK ApS (CVR 32347908) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,016,932 and a net result of DKK 238,536 compared with DKK 22,671 the year before. That is an increase of 110.7% compared with the year before. Equity amounted to DKK 287,938. The solvency ratio was 25.9%.
- Gross Profit
- 1,016,932 kr.
- Profit/Loss
- 238,536 kr.
- Equity
- 287,938 kr.
- Total Assets
- 1,113,298 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1 mio. | 239 t. | 288 t. | - |
| 2016 | - | 483 t. | 23 t. | 49 t. | - |
Find more companies like IMMUNITRACK ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
As of August 31, 2017, Stephan Pascal Thorgrimsen has joined the board of directors of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frankild has joined the board of directors of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frederik Lamdahl Justesen is registered as chairman of IMMUNITRACK ApS.
As of August 31, 2017, Sune Frederik Lamdahl Justesen has stepped down as director of IMMUNITRACK ApS.
About IMMUNITRACK ApS
IMMUNITRACK ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2013. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 6 employees. In 2024, the company reported a gross profit of DKK 141,975,865 and a net result of DKK 110,009,470 compared with DKK -194,097 the year before. Equity amounted to DKK 21,211,816.